Literature DB >> 26405308

Zonisamide: Antipsychotic Weight Gain.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2015        PMID: 26405308      PMCID: PMC4567188          DOI: 10.1310/hpj5003-199

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  7 in total

Review 1.  Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.

Authors:  Lawrence Maayan; Julia Vakhrusheva; Christoph U Correll
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

2.  A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain.

Authors:  Susan L McElroy; Erin Winstanley; Nicole Mori; Brian Martens; Jessica McCoy; Dianna Moeller; Anna I Guerdjikova; Paul E Keck
Journal:  J Clin Psychopharmacol       Date:  2012-04       Impact factor: 3.153

3.  Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients.

Authors:  JaeHyoung Lim; Young-Hoon Ko; Sook-Haeng Joe; Changsu Han; Moon-Soo Lee; Jaewon Yang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-07-22       Impact factor: 5.067

4.  Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.

Authors:  Jess G Fiedorowicz; Del D Miller; Jeffrey R Bishop; Chadi A Calarge; Vicki L Ellingrod; William G Haynes
Journal:  Curr Psychiatry Rev       Date:  2012-02-01

5.  The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Ahmad Ghanizadeh; Mohammad Saeed Nikseresht; Ali Sahraian
Journal:  Schizophr Res       Date:  2013-04-11       Impact factor: 4.939

6.  Zonisamide-induced weight loss in schizophrenia: case series.

Authors:  Jaewon Yang; Moon-Soo Lee; Sook-Haeng Joe; In-Kwa Jung; Seung-Hyun Kim
Journal:  Clin Neuropharmacol       Date:  2010 Mar-Apr       Impact factor: 1.592

Review 7.  Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.

Authors:  Chandan Das; Guillermo Mendez; Sonal Jagasia; Lawrence A Labbate
Journal:  Ann Clin Psychiatry       Date:  2012-08       Impact factor: 1.567

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.